Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum enVVeno Medical Corp NVNO

enVVeno Medical Corporation is a late-stage clinical med-tech company. The Company is focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The Company is developing surgical and non-surgical replacement venous valves for patients suffering from severe Chronic Venous Insufficiency (CVI) of the deep venous system... see more

NDAQ:NVNO - Post Discussion

enVVeno Medical Corp > FDA LIFT-OFF
View:
Post by Teccing on Mar 09, 2024 5:57pm

FDA LIFT-OFF

Looks like positive results are on the verge of better days ahead for both patients and investors.
Comment by PierreC on Jul 31, 2024 10:28am
Still on progress: https://www.webmd.com/dvt/bioprosthetic-venous-valve-dvt "Why It’s Ground-Breaking The VenoValve is the first prosthetic valve that’s kept working 6 months after implants performed in studies. Other types of surgeries have been devised to repair or make new valves, or to transplant or transfer other veins, but they weren’t widely adopted because of poor results or ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities